Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue NEW CANAAN, CT--(Marketwire - November 12, 2008) - The Independent Data Monitoring Committee (IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor REsponse (OVATURE) Trial,...

Mi-Co's Mi-Forms Validated for FDA Regulation 21 CFR Part 11 Compliance RESEARCH TRIANGLE PARK, NC--(Marketwire - January 24, 2008) - Mi-Co, the mobile data capture software company, announced that its Mi-Forms e-forms system has been validated for compliance with FDA...

Pharmexa Files the First Phase III Application HOERSHOLM, Denmark, Feb. 1, 2006 (PRIMEZONE) -- Pharmexa has filed an application to obtain approval to initiate the phase III trial with GV1001 in Ireland. Further applications will be filed in a...

ProtoKinetix CEO and Scientific Advisory Board to Meet in Paris to Discuss Preliminary Results of Third Party RECAF Validation Studies VANCOUVER, British Columbia, April 15, 2004 (PRIMEZONE) -- ProtoKinetix Inc. (OTCBB:PKTX), announces today that it has received a preliminary report from their new Director of Medical Research in...